Antimicrobial peptides with high bioactivity against MDR isolates: Addressing public health concerns
Open Access
- 21 July 2025
- journal article
- Published by Elsevier in Microbial Pathogenesis
- Vol. 207, 107893
Abstract
No abstract availableKeywords
Funding Information
- Michael Smith Health Research BC
- Genome Canada
- Mitacs
- Genome British Columbia
This publication has 27 references indexed in Scilit:
- Mining the UniProtKB/Swiss‐Prot database for antimicrobial peptidesProtein Science, 2025
- De novo synthetic antimicrobial peptide design with a recurrent neural networkProtein Science, 2024
- Global burden of bacterial antimicrobial resistance in 2019: a systematic analysisThe Lancet, 2022
- Highly accurate protein structure prediction with AlphaFoldNature, 2021
- Microcin H47: A Class IIb Microcin with Potent Activity Against Multidrug Resistant EnterobacteriaceaeACS Infectious Diseases, 2020
- MMseqs2 enables sensitive protein sequence searching for the analysis of massive data setsNature Biotechnology, 2017
- LL-37-derived membrane-active FK-13 analogs possessing cell selectivity, anti-biofilm activity and synergy with chloramphenicol and anti-inflammatory activityBiochimica et Biophysica Acta (BBA) - Biomembranes, 2017
- Characterization of dual effects induced by antimicrobial peptides: Regulated cell death or membrane disruptionBiochimica et Biophysica Acta (BBA) - General Subjects, 2012
- Agar and broth dilution methods to determine the minimal inhibitory concentration (MIC) of antimicrobial substancesNature Protocols, 2008
- Knowledge‐based protein secondary structure assignmentProteins: Structure, Function, and Bioinformatics, 1995